These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 26863267)

  • 1. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Chen ML; Sundrud MS
    Inflamm Bowel Dis; 2016 May; 22(5):1157-67. PubMed ID: 26863267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in inflammatory bowel disease.
    Neurath MF
    Nat Rev Immunol; 2014 May; 14(5):329-42. PubMed ID: 24751956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
    Neurath MF
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota activation and regulation of innate and adaptive immunity.
    Alexander KL; Targan SR; Elson CO
    Immunol Rev; 2014 Jul; 260(1):206-20. PubMed ID: 24942691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.
    Zenewicz LA; Yancopoulos GD; Valenzuela DM; Murphy AJ; Stevens S; Flavell RA
    Immunity; 2008 Dec; 29(6):947-57. PubMed ID: 19100701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
    Bouguen G; Chevaux JB; Peyrin-Biroulet L
    World J Gastroenterol; 2011 Feb; 17(5):547-56. PubMed ID: 21350703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
    Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
    World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease.
    Gomez-Bris R; Saez A; Herrero-Fernandez B; Rius C; Sanchez-Martinez H; Gonzalez-Granado JM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for targeting cytokines in inflammatory bowel disease.
    Neurath MF
    Nat Rev Immunol; 2024 Aug; 24(8):559-576. PubMed ID: 38486124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical model of the roles of T cells in inflammatory bowel disease.
    Lo WC; Arsenescu RI; Friedman A
    Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into IBD Pathogenesis.
    Shih DQ; Targan SR
    Curr Gastroenterol Rep; 2009 Dec; 11(6):473-80. PubMed ID: 19903423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions.
    Panés J
    Acta Physiol Scand; 2001 Sep; 173(1):159-65. PubMed ID: 11678739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mucosal T lymphocytes in regulating intestinal inflammation.
    Uhlig HH; Powrie F
    Springer Semin Immunopathol; 2005 Sep; 27(2):167-80. PubMed ID: 15959782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.